IL115990A - Medicinal preparations containing a history of phosphocholine - Google Patents
Medicinal preparations containing a history of phosphocholineInfo
- Publication number
- IL115990A IL115990A IL11599095A IL11599095A IL115990A IL 115990 A IL115990 A IL 115990A IL 11599095 A IL11599095 A IL 11599095A IL 11599095 A IL11599095 A IL 11599095A IL 115990 A IL115990 A IL 115990A
- Authority
- IL
- Israel
- Prior art keywords
- phosphocholine
- estradiol
- testosterone
- derivative
- agent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/543—Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
- A61K47/544—Phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US34835594A | 1994-11-30 | 1994-11-30 |
Publications (2)
Publication Number | Publication Date |
---|---|
IL115990A0 IL115990A0 (en) | 1996-01-31 |
IL115990A true IL115990A (en) | 2002-11-10 |
Family
ID=23367654
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL11599095A IL115990A (en) | 1994-11-30 | 1995-11-14 | Medicinal preparations containing a history of phosphocholine |
Country Status (9)
Country | Link |
---|---|
US (2) | US5703063A (fr) |
EP (1) | EP0796112A4 (fr) |
JP (1) | JPH10509976A (fr) |
AU (1) | AU706267B2 (fr) |
BR (1) | BR9509938A (fr) |
CA (1) | CA2204902A1 (fr) |
HU (1) | HUT77514A (fr) |
IL (1) | IL115990A (fr) |
WO (1) | WO1996016680A1 (fr) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020032160A1 (en) * | 1995-02-24 | 2002-03-14 | Nyce Jonathan W. | Compositions & formulations with an epiandrosterone or a ubiquinone & kits & their use for treatment of asthma symptoms & for reducing adenosine/adenosine receptor levels |
US5660835A (en) * | 1995-02-24 | 1997-08-26 | East Carolina University | Method of treating adenosine depletion |
GB9610122D0 (en) * | 1996-05-15 | 1996-07-24 | Reckitt & Colmann Prod Ltd | Organic compositions |
CA2266404A1 (fr) * | 1996-09-17 | 1998-03-26 | Amur Pharmaceuticals, Inc. | Derives de medicaments phospholipidiques |
JP2002536335A (ja) * | 1999-02-03 | 2002-10-29 | スーパージェン インコーポレイテッド | ホスホコリン界面活性剤及びその使用 |
EP1161226B1 (fr) * | 1999-02-18 | 2004-05-26 | SuperGen, Inc. | Derives de promedicament lies a la phosphocholine |
AU2002303425A1 (en) * | 2001-04-24 | 2002-11-05 | Epigenesis Pharmaceuticals, Inc. | Composition, formulations and kit for treatment of respiratory and lung disease with non-glucocorticoid steroids and/or ubiquinone and a bronchodilating agent |
AU2002303427A1 (en) * | 2001-04-24 | 2002-11-05 | East Carolina University | Compositions and formulations with a non-glucocorticoid steroid and/or a ubiquinone and kit for treatment of respiratory and lung disease |
AU2002366774A1 (en) * | 2001-12-13 | 2003-07-09 | So-Yeop Han | A process for preparing n-acylated lysophosphatidylcholine and a pharmaceutical composition for treatment of metabolic bone disease comprising said compounds |
ATE371680T1 (de) * | 2002-01-16 | 2007-09-15 | Biocompatibles Uk Ltd | Polymerkonjugate |
EP1553954A4 (fr) * | 2002-06-17 | 2009-12-23 | Epigenesis Pharmaceuticals Llc | Dihydrate dehydroepiandrosterone et methodes de traitement de l'asthme ou de la broncho-pneumopathie obstructive chronique a l'aide de compositions associees |
US7405207B2 (en) | 2002-06-17 | 2008-07-29 | Epigenesis Pharmaceuticals, Inc. | Nebulizer formulations of dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compositions thereof |
GB0301014D0 (en) * | 2003-01-16 | 2003-02-19 | Biocompatibles Ltd | Conjugation reactions |
US20090263381A1 (en) * | 2003-07-31 | 2009-10-22 | Robinson Cynthia B | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anti-ige antibody for treatment of asthma or chronic obstructive pulmonary disease |
US20050043282A1 (en) * | 2003-07-31 | 2005-02-24 | Robinson Cynthia B. | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a lipoxygenase inhibitor for treatment of asthma or chronic obstructive pulmonary disease |
US20050026879A1 (en) * | 2003-07-31 | 2005-02-03 | Robinson Cynthia B. | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a tyrosine kinase inhibitor, delta opioid receptor antagonist, neurokinin receptor antagonist, or VCAM inhibitor for treatment of asthma or chronic obstructive pulmonary disease |
US20050026881A1 (en) * | 2003-07-31 | 2005-02-03 | Robinson Cynthia B. | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anti-IgE antibody for treatment of asthma or chronic obstructive pulmonary disease |
US20050026882A1 (en) * | 2003-07-31 | 2005-02-03 | Robinson Cynthia B. | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease |
US20050026880A1 (en) * | 2003-07-31 | 2005-02-03 | Robinson Cynthia B. | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a cromone for treatment of asthma or chronic obstructive pulmonary disease |
US20050038004A1 (en) * | 2003-07-31 | 2005-02-17 | Robinson Cynthia B. | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anticholinergic bronchodilator for treatment of asthma or chronic obstructive pulmonary disease |
US20090297611A1 (en) * | 2003-07-31 | 2009-12-03 | Robinson Cynthia B | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a tyrosine kinase inhibitor, delta opioid receptor antagonist, neurokinin receptor antagonist, or vcam inhibitor for treatment of asthma or chronic obstructive pulmonary disease |
US20050101545A1 (en) * | 2003-07-31 | 2005-05-12 | Robinson Cynthia B. | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anticholinergic bronchodilator for treatment of asthma or chronic obstructive pulmonary disease |
US20110209699A1 (en) * | 2003-07-31 | 2011-09-01 | Robinson Cynthia B | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a lipoxygenase inhibitor for treatment of asthma or chronic obstructive pulmonary disease |
US20090274676A1 (en) * | 2003-07-31 | 2009-11-05 | Robinson Cynthia B | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a pde-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease |
US20050026884A1 (en) * | 2003-07-31 | 2005-02-03 | Robinson Cynthia B. | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a beta-agonist bronchodilator for treatment of asthma or chronic obstructive pulmonary disease |
US20050026883A1 (en) * | 2003-07-31 | 2005-02-03 | Robinson Cynthia B. | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease |
US20050085430A1 (en) * | 2003-07-31 | 2005-04-21 | Robinson Cynthia B. | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease |
US20050113318A1 (en) * | 2003-07-31 | 2005-05-26 | Robinson Cynthia B. | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a beta-agonist bronchodilator for treatment of asthma or chronic obstructive pulmonary disease |
US20050026848A1 (en) * | 2003-07-31 | 2005-02-03 | Robinson Cynthia B. | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a methylxanthine derivative for treatment of asthma or chronic obstructive pulmonary disease |
US20050026890A1 (en) * | 2003-07-31 | 2005-02-03 | Robinson Cynthia B. | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an antihistamine for treatment of asthma or chronic obstructive pulmonary disease |
US20090285899A1 (en) * | 2003-07-31 | 2009-11-19 | Robinson Cynthia B | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a methylxanthine derivative for treatment of asthma or chronic obstructive pulmonary disease |
US20090285900A1 (en) * | 2003-07-31 | 2009-11-19 | Robinson Cynthia B | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a beta-agonist bronchodilator for treatment of asthma or chronic obstructive pulmonary disease |
US7547096B2 (en) | 2003-12-30 | 2009-06-16 | Applied Biosystems, Llc | Apparatus and methods of depositing fluid |
MXPA06011219A (es) | 2004-03-29 | 2007-05-08 | Univ South Florida | Tratamiento efectivo de tumores y cancer con triciribina y compuestos relacionados. |
AU2006328957C1 (en) * | 2005-12-23 | 2013-01-10 | Jado Technologies Gmbh | Means and methods for the treatment and prevention of allergic diseases |
US8703179B2 (en) * | 2006-05-11 | 2014-04-22 | Kimberly-Clark Worldwide, Inc. | Mucosal formulation |
JPWO2020116640A1 (ja) * | 2018-12-07 | 2021-10-21 | 国立大学法人 東京大学 | 薬物複合体、ポリマー複合体及び薬物送達用組成物 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB487493A (en) * | 1935-11-16 | 1938-06-21 | Naamlooze Vennootschap Organon | Production of biological preparations |
ATE17007T1 (de) * | 1981-08-12 | 1986-01-15 | Nattermann A & Cie | Neue o-alkyl-o-carbamoyl-glycero-phosphocholine und verfahren zu ihrer herstellung. |
CA1252778A (fr) * | 1983-08-25 | 1989-04-18 | Hoffmann-La Roche Limited/Hoffmann-La Roche Limitee | Steroides |
US4891208A (en) * | 1985-04-10 | 1990-01-02 | The Liposome Company, Inc. | Steroidal liposomes |
US4897385A (en) * | 1984-12-10 | 1990-01-30 | American Cyanamid Company | Antihypertensive phosphate derivatives |
DE3445949A1 (de) * | 1984-12-17 | 1986-06-19 | A. Nattermann & Cie GmbH, 5000 Köln | Verfahren zur isolierung eines begleitphospholipid-freien phosphatidylcholins |
US4780455A (en) * | 1985-04-12 | 1988-10-25 | The Trustees Of Columbia University In The City Of New York | Lipophilic complexes of pharmacologically active organic compounds |
US4916249A (en) * | 1985-07-03 | 1990-04-10 | Hans Brachwitz | Glycero-3(2)-phospho-L-serine derivatives and salts thereof |
DE3827362A1 (de) * | 1988-08-12 | 1990-02-15 | Basf Ag | Pulvrige, hydrophile theophyllinformulierung und verfahren zur ihrer herstellung |
US5411947A (en) * | 1989-06-28 | 1995-05-02 | Vestar, Inc. | Method of converting a drug to an orally available form by covalently bonding a lipid to the drug |
US5194654A (en) * | 1989-11-22 | 1993-03-16 | Vical, Inc. | Lipid derivatives of phosphonoacids for liposomal incorporation and method of use |
EP0663816A4 (fr) * | 1992-10-08 | 1996-04-03 | Shaman Pharmaceuricals Inc | Classe nouvelle de derives de phosphocholine a activite fongicide. |
US5529989A (en) * | 1995-01-09 | 1996-06-25 | Arizona Board Of Regents Acting On Behalf Of Arizona State University | Pancratistatin prodrug |
-
1995
- 1995-11-09 HU HU9702239A patent/HUT77514A/hu unknown
- 1995-11-09 AU AU41661/96A patent/AU706267B2/en not_active Ceased
- 1995-11-09 CA CA002204902A patent/CA2204902A1/fr not_active Abandoned
- 1995-11-09 JP JP8518886A patent/JPH10509976A/ja not_active Ceased
- 1995-11-09 WO PCT/US1995/015100 patent/WO1996016680A1/fr not_active Application Discontinuation
- 1995-11-09 EP EP95940055A patent/EP0796112A4/fr not_active Withdrawn
- 1995-11-09 BR BR9509938A patent/BR9509938A/pt not_active Application Discontinuation
- 1995-11-14 IL IL11599095A patent/IL115990A/en not_active IP Right Cessation
-
1996
- 1996-11-12 US US08/748,025 patent/US5703063A/en not_active Expired - Fee Related
-
1997
- 1997-09-05 US US08/924,324 patent/US5888990A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP0796112A4 (fr) | 1999-12-01 |
AU4166196A (en) | 1996-06-19 |
AU706267B2 (en) | 1999-06-10 |
US5888990A (en) | 1999-03-30 |
HUT77514A (hu) | 1998-05-28 |
WO1996016680A1 (fr) | 1996-06-06 |
EP0796112A1 (fr) | 1997-09-24 |
BR9509938A (pt) | 1998-01-27 |
CA2204902A1 (fr) | 1996-06-06 |
JPH10509976A (ja) | 1998-09-29 |
US5703063A (en) | 1997-12-30 |
IL115990A0 (en) | 1996-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5888990A (en) | Phosphocholine drug derivatives | |
US6127349A (en) | Phospholipid drug derivatives | |
US7060290B1 (en) | Phosphocholine linked prodrug derivatives | |
EP0618800B1 (fr) | Derives steroidiens glycosyles traversant des membranes biologiques et leur procede de production | |
US6384024B1 (en) | Bile salt conjugates | |
CN100558407C (zh) | 制备含有胆汁酸的澄清水溶液剂型 | |
EP2115140B1 (fr) | Promédicaments hydrosolubles à charge positive de 1H-imidazo[4,5-c]quinolin-4-amines et composés associés a taux éléves de pénétration cutanée | |
US20170022244A1 (en) | Bone-selective osteogenic oxysterol bisphosphonate analogs | |
NO317063B1 (no) | Anvendelse av UDCA (ursodeoksycholinsyre) for forebyggelse og behandling av leversykdom hos pattedyr | |
US5830432A (en) | Phospholipid drug derivatives | |
WO1993022334A1 (fr) | Compositions pharmaceutiques et procedes pour l'apport de corticosteroides au colon | |
LT4441B (lt) | Antigliukokortikoidinis vaistinis preparatas | |
KR102467932B1 (ko) | 간을 표적으로 하는 특정 리간드와 갑상선 호르몬 수용체 작용제를 포함하는 약물 | |
Thakkar | Solubilization of some steroid hormones in aqueous solutions of bile salts | |
Gunnarsson et al. | The hydrolysis of estramustine phosphate; in vitro studies | |
US6489369B1 (en) | Phosphocholine surfactants and their use | |
EP3598982A1 (fr) | Bioconjugués de dérivés de neuropeptides | |
JP5201546B2 (ja) | N‐アセチルシステイン抱合型胆汁酸、それを含有する医薬組成物及びその製造方法 | |
Shao | Nasal drug absorption enhancement by chemical promoter incorporation and ester prodrug design | |
WO1991008748A1 (fr) | Synthese de saccharides recepteurs de rotavirus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
MM9K | Patent not in force due to non-payment of renewal fees |